Login to Your Account

NeoGenesis, Aventis Pharma In Multiyear Infectious Disease Deal

By Kim Coghill

Friday, February 15, 2002
NeoGenesis Pharmaceuticals Inc. said Thursday it will use its chemical genomics technologies to identify therapeutic agents for infectious diseases in a multiyear collaboration with Aventis Pharma SA. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription